Role of PI3K, MAPK/ERK 1/2, and p38 in Production of Erythropoietic Activity by Bone Marrow Cells after Blood Loss


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The leading role in the regulation of erythropoietic activity of adherent bone marrow cells under conditions of post-hemorrhagic anemia is played by classical MAP kinase pathway (ERK pathway). Erythropoietin is not the decisive factor in the formation of erythropoietic activity of adherent cells. PI3K, MAPK/ERK 1/2, and p38-signaling proteins are not the main regulators of local production of erythropoietin after 30% loss of circulating blood volume.

Sobre autores

V. Zhdanov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Rússia, Tomsk

L. Miroshnichenko

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Autor responsável pela correspondência
Email: laarmi@yandex.ru
Rússia, Tomsk

E. Udut

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Rússia, Tomsk

G. Zyuz’kov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Rússia, Tomsk

T. Khrichkova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Rússia, Tomsk

E. Simanina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Rússia, Tomsk

E. Sherstoboev

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Rússia, Tomsk

L. Stavrova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Rússia, Tomsk

V. Agafonov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Rússia, Tomsk

A. Chaikovskii

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Rússia, Tomsk

M. Minakova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Rússia, Tomsk

A. Dygai

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: laarmi@yandex.ru
Rússia, Tomsk


Declaração de direitos autorais © Springer Science+Business Media New York, 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies